Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases. TORONTO,...
Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase™ platform gene editors to build a pipeline of treatments for serious genetic diseases. TORONTO,...
Award to help fund preclinical studies to apply Specific Biologics' Dualase™ gene editing platform as a potential treatment for cystic fibrosis patients with nonsense genetic mutations. TORONTO, Dec. ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.